Fund Holdings — Darwin Global Management, Ltd.

Total Portfolio Value:
$3.77B
Total Bought:
$504.41M
Total Sold:
$1.44B
Net Transaction:
-$931.81M
Notable People:
Sarah Elizabeth Monime
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Insmed Incorporated(INSM)20,933,27716,805,184-4,128,093$3.64B$2.58B68.33%-$1.07B
Belite Bio, IncADS(BLTE)3,027,7043,057,412+29,708$486.92M$456.10M12.10%-$30.81M
ABIVAX Société AnonymeADS(ABVX)3,178,5013,468,657+290,156$439.71M$352.07M9.34%-$87.65M
Revolution Medicines, Inc.(RVMD)02,211,018+2,211,018$0$204.98M5.44%+$204.98M
Roivant Sciences Ltd.SHS(ROIV)06,797,300+6,797,300$0$179.52M4.76%+$179.52M
Dianthus Therapeutics, Inc.(DNTH)017,357+17,357$0$1.46M0.04%+$1.46M
Capricor Therapeutics, Inc.(CAPR)800,0000-800,000$23.17M$0—-$23.17M
Cidara Therapeutics Inc997,1960-997,196$220.18M$0—-$220.18M
Wave Life Sciences, Inc.SHS(WVE)7,298,4210-7,298,421$125.17M$0—-$125.17M
Page 1 of 1
Darwin Global Management, Ltd. — 13F Holdings — Q1 2026 | TickerTrail